Category: Industrial Agricultural Biotech

Invented by David M. Goldenberg, Serengulam V. Govindan, Immunomedics Inc The market for Antibody-drug conjugates (ADCs) is rapidly growing, driven by their potential to revolutionize cancer treatment. ADCs are a class of targeted therapies that combine the specificity of monoclonal antibodies with the cytotoxicity of small molecule drugs. This unique combination allows for highly targeted…

Invented by Herman Waldmann, Lisa K Gilliland, Masahide Tone, Mark R Frewin, Louise Walsh, Oxford University Innovation Ltd The market for antibody variants has been rapidly growing in recent years, driven by the increasing demand for personalized medicine and targeted therapies. Antibodies are proteins produced by the immune system to identify and neutralize foreign substances,…

Invented by Chien-Hsing Chang, David M. Goldenberg, Immunomedics Inc cancers. The market for combination therapies in cancer treatment is constantly evolving, with researchers and pharmaceutical companies striving to find new ways to overcome resistance and improve patient outcomes. One promising combination that has shown great potential is the use of ABCG2 inhibitors in conjunction with…

Invented by Matthew Bernett, Seung Chu, Gregory Moore, John Desjarlais, Xencor Inc The market for bispecific antibodies that bind to CD38 and CD3 is rapidly growing, thanks to their potential in treating various types of cancer. CD38 is a cell surface protein that is highly expressed on multiple myeloma cells, while CD3 is a protein…

Invented by Johan Lantto, Thomas Bouquin, Klaus Koefoed, Torben Gjetting, Vikram Kjoller BHATIA, Monika Gad, Gunther Roland GALLER, Camilla Frohlich, Laboratoires Servier SAS The market for Anti-PD-1 antibodies, compositions, and formulations has been rapidly growing in recent years. Anti-PD-1 antibodies are a class of immunotherapy drugs that have revolutionized the treatment of various types of…

Invented by Brian Wong, Julie Hambleton, Robert Sikorski, Emma Masteller, Kevin Hestir, David Bellovin, Katherine E. Lewis, Bristol Myers Squibb Co, Five Prime Therapeutics Inc The market for combination therapy of anti-CSF1R and anti-PD-1 antibodies for certain cancers has shown tremendous potential in recent years. This innovative approach to cancer treatment involves targeting two different…

Invented by Roger A. Sabbadini, William A. Garland, Genevieve Hansen, Steven Tarran Jones, David Gareth Williams, Apollo Endosurgery Inc The market for humanized antibodies and compositions for binding sphingosine-1-phosphate (S1P) has been rapidly growing in recent years. Humanized antibodies are a type of therapeutic antibody that is engineered to be more similar to human antibodies,…

Invented by Zhu Chen, Kenneth P. Ellsworth, James A. Milligan, Elizabeth Oldham, Dietmar Seiffert, Vaishnavi Ganti, Mohammad Tabrizifard, Bianka Prinz, Merck Sharp and Dohme LLC, Adimab LLC The market for anti-coagulation factor XI antibodies is experiencing significant growth due to the rising prevalence of cardiovascular diseases and the increasing demand for effective treatment options. Anti-coagulation…

Invented by Jozef Maria Hendrik Raats, Renato Gerardus Silvano Chirivi, Citryll BV, Citryll Ip BV The market for anti-inflammatory agents has experienced significant growth in recent years, driven by an increasing prevalence of chronic inflammatory diseases and a growing aging population. Anti-inflammatory agents are medications that help reduce inflammation in the body, providing relief from…

Invented by David W. Morris, Marc S. Malandro, Albert Lai, Christin Tse, Ali Fattaey, Sagres Discovery Inc The market for therapeutic targets for cancer has been growing rapidly in recent years, driven by advancements in our understanding of the disease and the development of innovative treatment options. Cancer remains one of the leading causes of…